the right treatment for the right patient at the right time
Cardiac Resynchronization Therapy
the most efficient device therapy for heart failure has important shortcomings...
Cardiac Resynchronization Therapy (CRT) improves mortality and morbidity for heart failure patients. However, not all patients who get a CRT device respond to therapy, and a subset of patients may get worse. Optimizing therapy by selecting the right patients will improve the cost-effectiveness and ensure proper utilization of this powerful therapy. Our system solves the problem by accurately identify the patients who will benefit from therapy and provide guidance for an optimal response for all patients.
a robust implantation supervision
1. Select the right patient based on novel measures
2. Optimize lead position for individualized therapy
3. Validate the implantation for acute precision medicine
The PaCRTool system is established in the implantation lab and connected to the fluoroscopy system. The PaCRTool System consists of a Signal Amplifier connecting to the patient with ECG, EGM, and a sensor catheter, a workstation for measurement processing and system control, a main screen for procedural display, and an angle sensor to instantaneously syncing the PaCRTool model with live X-ray. MRI/CT or ultrasound can be utilized in the system.
Pacertool has been developed based on initially internal research at Oslo University Hospital and then through a national research project. It is based on three filed patents, two novel non-invasive measurement methods, and more than 5 years of extensive research and clinical testing. The PaCRTool system has been tested in two clinical observational studies with 26 and 19 patients resulting in a response rate of 93%. These findings will soon be published in peer-review journals. The ambition of the founders is to change the way current CRT is performed and deliver the new standard of care for CRT treatment by providing real-time comprehensive guidance to the operator with no burden to the patient.